Identifying initiation and elongation inhibitors of dengue virus RNA polymerase in a high-throughput lead-finding campaign

Thomas M. Smith, Siew Pheng Lim, Kimberley Yue, Scott A. Busby, Rishi Arora, Cheah Chen Seh, S. Kirk Wright, Razvan Nutiu, Pornwaratt Niyomrattanakit, Kah Fei Wan, David Beer, Pei-Yong Shi, Timothy E. Benson

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Dengue virus (DENV) is the most significant mosquito-borne viral pathogen in the world and is the cause of dengue fever. The DENV RNA-dependent RNA polymerase (RdRp) is conserved among the four viral serotypes and is an attractive target for antiviral drug development. During initiation of viral RNA synthesis, the polymerase switches from a "closed" to "open" conformation to accommodate the viral RNA template. Inhibitors that lock the "closed" or block the "open" conformation would prevent viral RNA synthesis. Herein, we describe a screening campaign that employed two biochemical assays to identify inhibitors of RdRp initiation and elongation. Using a DENV subgenomic RNA template that promotes RdRp de novo initiation, the first assay measures cytosine nucleotide analogue (Atto-CTP) incorporation. Liberated Atto fluorophore allows for quantification of RdRp activity via fluorescence. The second assay uses the same RNA template but is label free and directly detects RdRp-mediated liberation of pyrophosphates of native ribonucleotides via liquid chromatography-mass spectrometry. The ability of inhibitors to bind and stabilize a "closed" conformation of the DENV RdRp was further assessed in a differential scanning fluorimetry assay. Last, active compounds were evaluated in a renilla luciferase-based DENV replicon cell-based assay to monitor cellular efficacy. All assays described herein are medium to high throughput, are robust and reproducible, and allow identification of inhibitors of the open and closed forms of DENV RNA polymerase.

Original languageEnglish (US)
Pages (from-to)153-163
Number of pages11
JournalJournal of Biomolecular Screening
Volume20
Issue number1
DOIs
StatePublished - Jan 30 2015
Externally publishedYes

Fingerprint

RNA Replicase
Dengue Virus
DNA-Directed RNA Polymerases
Viruses
Elongation
Assays
Throughput
Viral RNA
Conformations
Cytosine Nucleotides
Renilla Luciferases
RNA
Ribonucleotides
Cytidine Triphosphate
Fluorometry
Replicon
Dengue
Fluorophores
Diphosphates
Liquid chromatography

Keywords

  • assay
  • dengue virus
  • Flaviviridae
  • inhibitor
  • LCMS
  • RdRp
  • RNA-dependent RNA polymerase

ASJC Scopus subject areas

  • Analytical Chemistry
  • Drug Discovery
  • Pharmacology
  • Biochemistry
  • Molecular Medicine
  • Biotechnology
  • Medicine(all)

Cite this

Identifying initiation and elongation inhibitors of dengue virus RNA polymerase in a high-throughput lead-finding campaign. / Smith, Thomas M.; Lim, Siew Pheng; Yue, Kimberley; Busby, Scott A.; Arora, Rishi; Seh, Cheah Chen; Kirk Wright, S.; Nutiu, Razvan; Niyomrattanakit, Pornwaratt; Wan, Kah Fei; Beer, David; Shi, Pei-Yong; Benson, Timothy E.

In: Journal of Biomolecular Screening, Vol. 20, No. 1, 30.01.2015, p. 153-163.

Research output: Contribution to journalArticle

Smith, TM, Lim, SP, Yue, K, Busby, SA, Arora, R, Seh, CC, Kirk Wright, S, Nutiu, R, Niyomrattanakit, P, Wan, KF, Beer, D, Shi, P-Y & Benson, TE 2015, 'Identifying initiation and elongation inhibitors of dengue virus RNA polymerase in a high-throughput lead-finding campaign', Journal of Biomolecular Screening, vol. 20, no. 1, pp. 153-163. https://doi.org/10.1177/1087057114551141
Smith, Thomas M. ; Lim, Siew Pheng ; Yue, Kimberley ; Busby, Scott A. ; Arora, Rishi ; Seh, Cheah Chen ; Kirk Wright, S. ; Nutiu, Razvan ; Niyomrattanakit, Pornwaratt ; Wan, Kah Fei ; Beer, David ; Shi, Pei-Yong ; Benson, Timothy E. / Identifying initiation and elongation inhibitors of dengue virus RNA polymerase in a high-throughput lead-finding campaign. In: Journal of Biomolecular Screening. 2015 ; Vol. 20, No. 1. pp. 153-163.
@article{9a9e3baf759d48b8bd917815d3767f01,
title = "Identifying initiation and elongation inhibitors of dengue virus RNA polymerase in a high-throughput lead-finding campaign",
abstract = "Dengue virus (DENV) is the most significant mosquito-borne viral pathogen in the world and is the cause of dengue fever. The DENV RNA-dependent RNA polymerase (RdRp) is conserved among the four viral serotypes and is an attractive target for antiviral drug development. During initiation of viral RNA synthesis, the polymerase switches from a {"}closed{"} to {"}open{"} conformation to accommodate the viral RNA template. Inhibitors that lock the {"}closed{"} or block the {"}open{"} conformation would prevent viral RNA synthesis. Herein, we describe a screening campaign that employed two biochemical assays to identify inhibitors of RdRp initiation and elongation. Using a DENV subgenomic RNA template that promotes RdRp de novo initiation, the first assay measures cytosine nucleotide analogue (Atto-CTP) incorporation. Liberated Atto fluorophore allows for quantification of RdRp activity via fluorescence. The second assay uses the same RNA template but is label free and directly detects RdRp-mediated liberation of pyrophosphates of native ribonucleotides via liquid chromatography-mass spectrometry. The ability of inhibitors to bind and stabilize a {"}closed{"} conformation of the DENV RdRp was further assessed in a differential scanning fluorimetry assay. Last, active compounds were evaluated in a renilla luciferase-based DENV replicon cell-based assay to monitor cellular efficacy. All assays described herein are medium to high throughput, are robust and reproducible, and allow identification of inhibitors of the open and closed forms of DENV RNA polymerase.",
keywords = "assay, dengue virus, Flaviviridae, inhibitor, LCMS, RdRp, RNA-dependent RNA polymerase",
author = "Smith, {Thomas M.} and Lim, {Siew Pheng} and Kimberley Yue and Busby, {Scott A.} and Rishi Arora and Seh, {Cheah Chen} and {Kirk Wright}, S. and Razvan Nutiu and Pornwaratt Niyomrattanakit and Wan, {Kah Fei} and David Beer and Pei-Yong Shi and Benson, {Timothy E.}",
year = "2015",
month = "1",
day = "30",
doi = "10.1177/1087057114551141",
language = "English (US)",
volume = "20",
pages = "153--163",
journal = "Journal of Biomolecular Screening",
issn = "1087-0571",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Identifying initiation and elongation inhibitors of dengue virus RNA polymerase in a high-throughput lead-finding campaign

AU - Smith, Thomas M.

AU - Lim, Siew Pheng

AU - Yue, Kimberley

AU - Busby, Scott A.

AU - Arora, Rishi

AU - Seh, Cheah Chen

AU - Kirk Wright, S.

AU - Nutiu, Razvan

AU - Niyomrattanakit, Pornwaratt

AU - Wan, Kah Fei

AU - Beer, David

AU - Shi, Pei-Yong

AU - Benson, Timothy E.

PY - 2015/1/30

Y1 - 2015/1/30

N2 - Dengue virus (DENV) is the most significant mosquito-borne viral pathogen in the world and is the cause of dengue fever. The DENV RNA-dependent RNA polymerase (RdRp) is conserved among the four viral serotypes and is an attractive target for antiviral drug development. During initiation of viral RNA synthesis, the polymerase switches from a "closed" to "open" conformation to accommodate the viral RNA template. Inhibitors that lock the "closed" or block the "open" conformation would prevent viral RNA synthesis. Herein, we describe a screening campaign that employed two biochemical assays to identify inhibitors of RdRp initiation and elongation. Using a DENV subgenomic RNA template that promotes RdRp de novo initiation, the first assay measures cytosine nucleotide analogue (Atto-CTP) incorporation. Liberated Atto fluorophore allows for quantification of RdRp activity via fluorescence. The second assay uses the same RNA template but is label free and directly detects RdRp-mediated liberation of pyrophosphates of native ribonucleotides via liquid chromatography-mass spectrometry. The ability of inhibitors to bind and stabilize a "closed" conformation of the DENV RdRp was further assessed in a differential scanning fluorimetry assay. Last, active compounds were evaluated in a renilla luciferase-based DENV replicon cell-based assay to monitor cellular efficacy. All assays described herein are medium to high throughput, are robust and reproducible, and allow identification of inhibitors of the open and closed forms of DENV RNA polymerase.

AB - Dengue virus (DENV) is the most significant mosquito-borne viral pathogen in the world and is the cause of dengue fever. The DENV RNA-dependent RNA polymerase (RdRp) is conserved among the four viral serotypes and is an attractive target for antiviral drug development. During initiation of viral RNA synthesis, the polymerase switches from a "closed" to "open" conformation to accommodate the viral RNA template. Inhibitors that lock the "closed" or block the "open" conformation would prevent viral RNA synthesis. Herein, we describe a screening campaign that employed two biochemical assays to identify inhibitors of RdRp initiation and elongation. Using a DENV subgenomic RNA template that promotes RdRp de novo initiation, the first assay measures cytosine nucleotide analogue (Atto-CTP) incorporation. Liberated Atto fluorophore allows for quantification of RdRp activity via fluorescence. The second assay uses the same RNA template but is label free and directly detects RdRp-mediated liberation of pyrophosphates of native ribonucleotides via liquid chromatography-mass spectrometry. The ability of inhibitors to bind and stabilize a "closed" conformation of the DENV RdRp was further assessed in a differential scanning fluorimetry assay. Last, active compounds were evaluated in a renilla luciferase-based DENV replicon cell-based assay to monitor cellular efficacy. All assays described herein are medium to high throughput, are robust and reproducible, and allow identification of inhibitors of the open and closed forms of DENV RNA polymerase.

KW - assay

KW - dengue virus

KW - Flaviviridae

KW - inhibitor

KW - LCMS

KW - RdRp

KW - RNA-dependent RNA polymerase

UR - http://www.scopus.com/inward/record.url?scp=84920081623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920081623&partnerID=8YFLogxK

U2 - 10.1177/1087057114551141

DO - 10.1177/1087057114551141

M3 - Article

VL - 20

SP - 153

EP - 163

JO - Journal of Biomolecular Screening

JF - Journal of Biomolecular Screening

SN - 1087-0571

IS - 1

ER -